12月15日，奥精医疗大宗交易成交15万股，成交额294.3万元，占当日总成交额的3.52%，成交价19.62 元，较市场收盘价20.02元折价2%。 ...

Group 1 - The core transaction on December 11 involved a block trade of 120,000 shares of Aojing Medical, with a transaction value of 2.328 million yuan, at a price of 19.40 yuan, which represents a discount of 2.02% compared to the closing price of the day [1][2] - In the last three months, Aojing Medical has recorded a total of 7 block trades, amounting to a cumulative transaction value of 44.3038 million yuan [2] - The closing price of Aojing Medical on the day of the report was 19.80 yuan, reflecting a decrease of 1.20%, with a daily turnover rate of 2.58% and a total trading volume of 70.4893 million yuan [2] Group 2 - The net inflow of main funds for Aojing Medical on that day was 2.7902 million yuan, and over the past five days, the stock has increased by 2.86%, with a total net inflow of 30.9281 million yuan [2] - The latest margin financing balance for Aojing Medical is 163 million yuan, which has decreased by 1.8002 million yuan over the past five days, representing a decline of 1.09% [2]

从参与大宗交易的营业部看，买方或卖方营业部为机构的成交共有4笔，涉及3只股，机构买入金额居前 的为沪硅产业、金天钛业、通源环境等，买入金额分别为4204.00万元、1854.00万元、318.30万元，机 构卖出金额居前的有金天钛业等，卖出金额分别为1853.00万元。 7只科创板股大宗交易平台今日发生交易，合计成交2.24亿元。 证券时报·数据宝统计显示，12月11日共有7只科创板股发生大宗交易，合计成交15笔，累计成交量 1159.08万股，成交额合计2.24亿元。 统计显示，成交金额最多的是沪硅产业，共有2笔大宗交易，合计成交量为420.00万股，成交金额合计 8828.40万元；其次是金天钛业、神工股份，今日大宗交易金额分别为5556.00万元、3338.71万元。 折溢价情况来看，今日出现大宗交易的科创板股中，均为折价成交，大宗交易成交价格相对收盘价折价 率居前的有通源环境、圣诺生物、奥精医疗等，折价率分别为23.67%、8.69%、2.02%。 股价表现方面，今日科创50指数下跌1.55%，科创板股中，今日上涨的有115只，占19.33%，今日发生 大宗交易的科创板股平均上涨0.05%，其中，涨幅 ...

奥精医疗12月10日大宗交易平台出现一笔成交，成交量12.00万股，成交金额235.68万元，大宗交易成交 价为19.64元，相对今日收盘价折价2.00%。该笔交易的买方营业部为长城证券股份有限公司上海长宁区 延安西路证券营业部，卖方营业部为华泰证券股份有限公司南京中山东路华泰证券大厦证券营业部。 进一步统计，近3个月内该股累计发生7笔大宗交易，合计成交金额为4698.38万元。 证券时报·数据宝统计显示，奥精医疗今日收盘价为20.04元，下跌1.13%，日换手率为4.61%，成交额为 1.29亿元，全天主力资金净流入1601.17万元，近5日该股累计上涨2.93%，近5日资金合计净流入2691.09 万元。 两融数据显示，该股最新融资余额为1.64亿元，近5日减少430.07万元，降幅为2.55%。（数据宝） 12月10日奥精医疗大宗交易一览 | 成交量 | 成交金 | 成交价 | 相对当日收 | | | | --- | --- | --- | --- | --- | --- | | （万 | 额（万 | 格 | 盘折溢价 | 买方营业部 | 卖方营业部 | | 股） | 元） | （元） | （%） | ...

| APA 212"s within children il box 11, 2017 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量( *) 买入营业部 | | | | 奥出营业部 | 是否为专场 | | 025-12-10 | 奥精医疗 | 688613 | 19.64 12 | 235.68 | 长城县经营管理 | 套製酵製 | | Ka | 12月10日，奥精医疗大宗交易成交12万股，成交额235.68万元，占当日总成交额的1.8%，成交价19.64 元，较市场收盘价20.04元折价2%。 ...

两融数据显示，该股最新融资余额为1.54亿元，近5日减少1423.14万元，降幅为8.45%。（数据宝） 奥精医疗12月8日大宗交易平台出现一笔成交，成交量12.00万股，成交金额231.00万元，大宗交易成交 价为19.25元，相对今日收盘价折价1.99%。该笔交易的买方营业部为长城证券股份有限公司上海长宁区 延安西路证券营业部，卖方营业部为华泰证券股份有限公司南京中山东路华泰证券大厦证券营业部。 进一步统计，近3个月内该股累计发生8笔大宗交易，合计成交金额为5756.60万元。 证券时报•数据宝统计显示，奥精医疗今日收盘价为19.64元，上涨0.31%，日换手率为1.81%，成交额为 4879.13万元，全天主力资金净流出345.92万元，近5日该股累计下跌1.65%，近5日资金合计净流出 1220.22万元。 | | | | 相对当 | | | | --- | --- | --- | --- | --- | --- | | 成交 | 成交 | 成交价 | 日 | | | | 量 | 金额 | 格 | 收盘折 | 买方营业部 | 卖方营业部 | | （万 | （万 | （元） | 溢价 | | | | 股 ...

证券代码： 688613 证券简称：奥精医疗 公告编号： 2025-065 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会证监许可[2021]1219号《关于同意奥精医疗 科技股份有限公司首次公开发行股票注册的批复》批准，并经上海证券交易 所同意，公司向社会公开发行人民币普通股（A股）股票3,333.3334万股，每 股发行价格16.43元，募集资金总额为人民币547,666,677.62元，扣除不含税 的发行费用后募集资金净额为人民币500,816,913.05元。公司上述募集资金 已于2021年5月17日到账。以上募集资金到位情况，已经立信会计师事务所 （特殊普通合伙）验证，并出具了首次发行《验资报告》（信会师报字[2021] 第ZB11115号）。公司已在银行开设了专户存储上述募集资金。 二、《募集资金专户存储监管协议》的签订情况和募集资金专户的开立情 况 公司于2025年6月25日召开了第二届董事会第十四次会议及第二届监事会 第十三次会议审议通过了《关于部分募投项目调 ...

| A 200 - 10 - 1 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 交易日期 | 证券简称 | 证券代码 | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | | 卖出营业部 是否为专场 | | 025-12-08 | 奥精医疗 | 688613 | 19.25 231 | 12 | 长城县经营管理 | 藝術教學 KO | 12月8日，奥精医疗大宗交易成交12万股，成交额231万元，占当日总成交额的4.52%，成交价19.25元， 较市场收盘价19.64元折价1.99%。 ...

Core Viewpoint - The announcement details the election of the third board of directors for Aojing Medical Technology Co., Ltd., including the appointment of a staff representative director and the restructuring of the board and management team [1][5][6]. Board Election and Restructuring - Aojing Medical held its third extraordinary general meeting on November 26, 2025, where the election of the third board of directors was approved, consisting of 9 directors, including 1 staff representative director [1][6]. - Helen Han Cui was elected as the staff representative director during the first staff representative assembly on November 26, 2025 [1][2]. - The newly elected board includes 5 non-independent directors and 3 independent directors, with a term of three years [1][8]. Management Appointments - The first meeting of the third board of directors approved the election of Huang Wanlan as the chairman and appointed new senior management, including Qiu Zhiye as the general manager and Tian Guofeng and Song Tianxi as deputy general managers [7][10]. - Wang Ling was appointed as the financial officer and also serves as the board secretary [10][14]. Legal Compliance and Qualifications - All elected directors and appointed senior management meet the qualifications set forth by the Company Law and the company's articles of association, with no disqualifications reported [4][11][15]. - The company has canceled its supervisory board, transferring its responsibilities to the audit committee of the board [12][13]. Shareholder Meeting and Voting - The extraordinary general meeting was conducted in compliance with legal requirements, with no resolutions being rejected [16][23]. - The voting process included both on-site and online participation, ensuring transparency and adherence to regulations [16][18].

Core Points - The company announced the convening of its first employee representative assembly for 2025 on November 26, 2025 [1] - Helen Han Cui has been elected as the employee representative director for the company's third board of directors [1]